A longitudinal study of cerebrospinal fluid beta‐endorphin‐like immunoreactivity in delirium: changes at the acute stage and at one‐year follow‐up
- 1 October 1990
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 82 (4) , 323-326
- https://doi.org/10.1111/j.1600-0447.1990.tb01394.x
Abstract
Cerebrospinal fluid beta-endorphin-like immunoreactivity (CSF BLI) was determined on 3 occasions for elderly delirious patients and the BLI levels were compared with age-equivalent controls. Delirious patients showed a significant reduction in the BLI values in the first sample and a declining trend was seen in the follow-up. The results suggest a role for beta- endorphinergic dysfunction in the genesis of some symptoms of delirium, and this dysfunction may be a common phenomenon in various forms of delirium and dementia.Keywords
This publication has 22 references indexed in Scilit:
- Beta endorphin levels in CSF during methadone maintenanceLife Sciences, 1987
- The Opioids, Dopamine, Cholecystokinin, and Eating DisordersClinical Neuropharmacology, 1986
- Delirium: The Often Overlooked DiagnosisThe International Journal of Psychiatry in Medicine, 1985
- Neuropeptides in Human Memory and Learning ProcessesNeurosurgery, 1985
- Neuropeptides in human memory and learning processesNeurosurgery, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Decreased level of β-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer typeLife Sciences, 1983
- Combination of high pressure liquid chromatography and radioimmunoassay is a powerful tool for the specific and quantitative determination of endorphins and related peptidesBiochemical and Biophysical Research Communications, 1979
- ParkinsonismNeurology, 1967